Among 18 analysts covering Axalta Coating Systems (NYSE:AXTA), 12 have Buy rating, 2 Sell and 4 Hold.
AnaptysBio, Inc. most recently reported earnings per share (EPS) of -$1.73 for the June 2017 versus $1.18 in the same quarter previous year, representing -247% growth. The stock has "Outperform" rating by RBC Capital Markets on Wednesday, September 27. Berkshire Hathaway Inc owns $670.8 million in Axalta Coating Systems Ltd., which represents roughly 9.81% of the company's market cap and approximately 9.58% of the institutional ownership.
Several other research analysts have also commented on AXTA. Analysts reported that the Price Target for Axalta Coating Systems Ltd. might touch $39 high while the Average Price Target and Low price Target is $32.17 and $26 respectively.
Axalta Coating Systems Ltd.is a holding company. MA's may be used to identify uptrends or downtrends, and they can be a prominent indicator for detecting a shift in momentum for a particular stock. The stock has "Buy" rating by RBC Capital Markets on Thursday, July 13.
At the end of June reporting period, 149 institutional holders increased their position in Axalta Coating Systems Ltd. (NYSE:AXTA) by some 29,043,703 shares, 153 decreased positions by 21,728,393 and 40 held positions by 192,572,950. If you are accessing this story on another domain, it was illegally stolen and republished in violation of USA and global trademark and copyright laws.
Renaissance Technologies LLC reduced its stake in Axalta Coating Systems Ltd (NASDAQ:AXTA) by 31.2% during the 2nd quarter, according to the company in its most recent filing with the SEC.
10/10/2017 - Axalta Coating Systems Ltd. was downgraded to "sell" by analysts at Citigroup. The stock witnessed -1.72% declines, -13.66% declines and -8.69% declines for the 1-month, 3-month and 6-month period, respectively.
Moving averages have the ability to be used as a powerful indicator for technical stock analysis. A stock with a price that fluctuates wildly, hits new highs and lows or moves erratically is considered highly volatile. These ratios are price to earnings, price to cash flow, EBITDA to EV, price to book value, and price to sales.
Axalta Coating Systems (NASDAQ:AXTA) last posted its quarterly earnings data on Thursday, August 3rd.
Looking forward, the company's quarterly earnings are expected to come at $0.35 in the three months through September 2017 and $0.38 in the quarter ending December 2017, reflecting 9.37% and 35.71% growth, respectively.
In the most updated research from a number of analysts on Wall Street, the company gets 6 Buys and 0 Sell among 6 analysts. The company's revenue for the quarter was up 2.3% on a year-over-year basis. After a recent check, it is observed that the insiders for the firm now own 0.60% shares. The stock has "Equal-Weight" rating by Barclays Capital on Friday, August 4. Following the completion of the acquisition, the director now directly owns 4,000 shares of the company's stock, valued at $112,640. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. The stock was sold at an average price of $30.00, for a total value of $1,046,220.00. The disclosure for this purchase can be found here. Insiders sold 626,756 shares of company stock valued at $19,580,505 in the last ninety days. Commonwealth Bank of Australia lifted its stake in shares of Axalta Coating Systems by 18.1% during the second quarter. Acrospire Investment Management LLC now owns 4,862 shares of the specialty chemicals company's stock valued at $156,000 after buying an additional 3,500 shares during the period.
12/02/2016 - Axalta Coating Systems Ltd. was downgraded to "hold" by analysts at Vertical Group.
Another recent and important Axalta Coating Systems Ltd (NYSE:AXTA) news was published by Nasdaq.com which published an article titled: "Steven Romick Buys Tencent Holdings, Porsche Automobil Holding SE, Axalta ..." on October 06, 2017. The Firm is a manufacturer, marketer and distributor of coatings systems primarily serving the transportation industry.